This week we welcome Katherine Eban to Trial by Data to discuss the need for global whistleblower protections, as well as why the industry needs to incentivize drug quality across both name brands and generics. Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.